ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

DCCP Payback System Saving $1 Million Year

December 3, 1982

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003

Ontak Approved For Lymphoma

October 31, 2008

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012